18F-Labeled Pyrido[3,4-d]pyrimidine as an Effective Probe for Imaging of L858R Mutant Epidermal Growth Factor Receptor.

about

18F-Labeled Pyrido[3,4-d]pyrimidine as an Effective Probe for Imaging of L858R Mutant Epidermal Growth Factor Receptor.

Item

http://www.wikidata.org/entity/Q53742828

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

18F-Labeled Pyrido[3,4-d]pyrim ...... dermal Growth Factor Receptor.

@en

18F-Labeled Pyrido[3,4-d]pyrim ...... dermal Growth Factor Receptor.

@nl

type

Item

label

18F-Labeled Pyrido[3,4-d]pyrim ...... dermal Growth Factor Receptor.

@en

18F-Labeled Pyrido[3,4-d]pyrim ...... dermal Growth Factor Receptor.

@nl

prefLabel

18F-Labeled Pyrido[3,4-d]pyrim ...... dermal Growth Factor Receptor.

@en

18F-Labeled Pyrido[3,4-d]pyrim ...... dermal Growth Factor Receptor.

@nl

P1476

18F-Labeled Pyrido[3,4-d]pyrim ...... dermal Growth Factor Receptor.

@en

P2093

Akira Makino

http://www.w3.org/2001/XMLSchema#string

Anna Miyazaki

http://www.w3.org/2001/XMLSchema#string

Haruka Okuda

http://www.w3.org/2001/XMLSchema#string

Hideo Saji

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Kimura

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Watanabe

http://www.w3.org/2001/XMLSchema#string

Ikuo Kawasaki

http://www.w3.org/2001/XMLSchema#string

Kenji Arimitsu

http://www.w3.org/2001/XMLSchema#string

Masahiro Ono

http://www.w3.org/2001/XMLSchema#string

Masumi Ishiguro

http://www.w3.org/2001/XMLSchema#string

P2860

Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a systematic review

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer

Epidermal growth factor receptor mutations in lung cancer

6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activity.

Identifying erlotinib-sensitive non-small cell lung carcinoma tumors in mice using [(11)C]erlotinib PET.

Novel therapeutic targets in non-small cell lung cancer.

Development of [18F]afatinib as new TKI-PET tracer for EGFR positive tumors.

Positron emission tomography (PET) imaging with [11C]-labeled erlotinib: a micro-PET study on mice with lung tumor xenografts.

Evaluation of [(18)F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors.

P304

418-422

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACSMEDCHEMLETT.6B00520

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yusuke Yagi

P577

2017-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28435529

http://www.w3.org/2001/XMLSchema#string

P932

5392762

http://www.w3.org/2001/XMLSchema#string